+49 30 648 35 164 service@chameleon-pharma.com

Who we are

About Us

We, Chameleon Pharma Consulting Group (CPC), are healthcare experts focused on Systematic Market Entry in Europe, CIS/CEE, Latin America, Asia, US/Canada, and the Middle East. At CPC we successfully conducted more than 300 market entry projects in the self-medication and Rx industry. We support pharma and OTC companies in entering new markets, developing market entry strategies, analyzing product portfolios for selected markets, and overcoming regulatory requirements more efficiently. All of our CPC experts have more than 20 years of practical experience in developing and launching Rx, MD, OTC, Phyto, Food Supplements, and Cosmetics throughout the world. With our knowledge and our extensive network of experts, we can guarantee a dynamic, flexible, and customer-oriented service.

Our Focus Segments

Our Focus Regions

RX

Medical Devices

Cosmetics

OTC / Phyto

Dermatology

Others

Latin America

Europe

Africa

Asia

USA/Canada

Middle East

Fundamental Market Entry Expertise

More than consultants, we are Consumer Health, Pharma and Medical Device Experts with many years of international market entry experience.

Our team consists of specialists across Strategy, Marketing, Business Development, Commercial Due Diligence, Licensing, M&A, and regulatory processes.

Customer-oriented

As healthcare experts with practical international experience, we understand that each company has its own world. 

Every single one of our clients has different needs and strengths to offer to new countries. That is why each project is unique for us, and we thrive to come up with the best-personalized market entry solution. 

We start where others stop, knowing that international market success does require local expert knowledge, drive and network.

Expert Knowledge

As a 100% healthcare expert company, we provide our clients with a wide range of Consulting Services focusing on Consumer Healthcare, Pharma Rx, MD, Cosmetics, Food Supplements, FMCG, Wholesale, Retail and Production. 

In our different offices around the world, our experts have more than 15 years of industry experience in the local healthcare industry. This allows CPC to offer our clients local detailed market insights and practical knowledge in our present regions.

Chameleon Pharma Consulting Group in numbers

World Markets covered

Years of practical experience

CPC Experts around the world

Rx, MD, OTC, Derma successful market entry projects

Chameleon Pharma CEO Reiner Christensen

Reiner Christensen

Group CEO

—————————————————

Reiner has 25 years of international experience in Rx, Medical Device, OTC, Phyto, Derma/Cosmetic, and Food Supplements products in General Management.

He has lived and worked in Asia, Russia/CIS, Latin America, and different European countries.

«At CPC, our purpose is to be your trusted advisor on global market entry strategies in the healthcare world»

Mr. Reiner Christensen

CEO, Chameleon Pharma Consulting Group

Chameleon Pharma Consulting experts photos and first names

Our Experts

All our 22 experts possess extensive experience with more than 20 years in the healthcare industry in Europe, the US, and the Emerging Markets in Asia, Latin America, and CIS. We bring a global understanding of industry opportunities and challenges to every client, every time. We provide our clients with a wide range of Pharma and Healthcare Consulting Services focusing on Consumer Healthcare, Pharma RxDerma, Medical Devices, Food Supplements, FMCG, Wholesale, Retail, Production.

20+ years of experience in the Healthcare industry

15 nationalities and more than 10 languages spoken

Related Posts

Ничего не найдено

Запрашиваемая страница не найдена. Попробуйте уточнить параметры поиска или используйте меню для нахождения страницы.

Our services

i

International Company Partner Identification

Licensing and
M&A

Product Potential & Country Analysis

International Business & Market Entry

U

Pharma Regulatory & Registration

Pharma Executive
Search

International Strategy & Analysis

Market Reports and Analysis

[/et_pb_section]